Purple BiotechPPBT
13F holders, Q1 2024 (March 31)21holders
2famous investors
$0.67avg. 13F price*
At the end of Q1 2024, 21 institutions reported holding Purple Biotech Ltd. (PPBT) in their 13F filings. The largest holders were Armistice Capital, LLC ($1.4M), Kingswood Wealth Advisors, LLC ($125K) and Morgan Stanley ($92K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Purple Biotech Ltd.
- CUSIP
- 74638P109
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $26K |
| Exits | 3 | $156K |
Ownership 21 holders
| Armistice Capital, LLC | 0.04% | Add +12.4% | 2,115,000 | $1.4M |
| Kingswood Wealth Advisors, LLC | 0.01% | Add +6.3% | 186,100 | $125K |
| Morgan Stanley | 0.00% | Add +57.9% | 136,610 | $92K |
| Citadel Advisors | 0.00% | Add +392.7% | 58,023 | $39K |
| XTX Topco Ltd | 0.00% | Add +114.6% | 29,099 | $19K |
| Millennium Management | 0.00% | New | 21,438 | $14K |
| Virtu Financial LLC | 0.00% | New | 16,078 | $11K |
| Venture Visionary Partners LLC | 0.00% | No change | 15,553 | $10K |
| Wealth Advisors of Iowa, LLC | 0.01% | No change | 14,270 | $10K |
| Geode Capital Management, LLC | 0.00% | No change | 12,666 | $8K |
| UBS Group AG | 0.00% | Add +480.6% | 11,611 | $8K |
| Raymond James & Associates | 0.00% | Reduce -9.1% | 10,000 | $7K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 4,000 | $4K |
| Group One Trading LLC | 0.00% | Reduce -5.2% | 3,206 | $2K |
| Royal Bank of Canada | 0.00% | Add +26875.0% | 2,158 | $1K |
| JPMorgan Chase & Co. | 0.00% | New | 859 | $575 |
| Global Retirement Partners, LLC | 0.00% | No change | 336 | $225 |
| North Star Investment Management Corp. | 0.00% | No change | 300 | $201 |
| Sound Income Strategies, LLC | 0.00% | No change | 100 | $67 |
| Rhumbline Advisers | 0.00% | Reduce -97.1% | 16 | $10 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 5 | $3 |
"% of holder's portfolio" is PPBT's weight in each manager's 13F, not the share of Purple Biotech Ltd. the manager owns.